Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2021-02-16 10:41 am Sale | 13G | CYMABAY THERAPEUTICS INC CBAY | Foresite Capital Fund III L.P. | 3,428,898 5% | -390,828 (-10.23%) | View |
| 2021-02-10 10:46 am Sale | 13G | CYMABAY THERAPEUTICS INC CBAY | VANGUARD GROUP INC | 3,427,011 4.97% | -264,314 (-7.16%) | View |
| 2021-01-29 09:57 am Sale | 13G | CYMABAY THERAPEUTICS INC CBAY | BlackRock Inc. BLK | 5,386,244 7.8% | -203,607 (-3.64%) | View |
| 2020-09-24 4:47 pm Purchase | 13G | CYMABAY THERAPEUTICS INC CBAY | Boxer Capital LLC | 4,000,000 5.8% | 4,000,000 (New Position) | View |
| 2020-09-01 12:25 pm Purchase | 13G | CYMABAY THERAPEUTICS INC CBAY | Avoro Capital Advisors LLC | 10,300,000 14.95% | 4,800,000 (+87.27%) | View |
| 2020-06-05 4:02 pm Purchase | 13G | CYMABAY THERAPEUTICS INC CBAY | D. E. SHAW & CO L.P. | 3,449,612 5% | 3,449,612 (New Position) | View |
| 2020-05-13 09:00 am Sale | 13D | CYMABAY THERAPEUTICS INC CBAY | ENGINE CAPITAL L.P. | 2,097,676 3% | -4,346,301 (-67.45%) | View |
| 2020-03-13 5:12 pm Sale | 13D | CYMABAY THERAPEUTICS INC CBAY | ENGINE CAPITAL L.P. | 6,443,977 9.4% | -243,276 (-3.64%) | View |
| 2020-02-14 5:02 pm Sale | 13G | CYMABAY THERAPEUTICS INC CBAY | Point72 Asset Management L.P. | 23,382 0.1% | -4,306,360 (-99.46%) | View |
| 2020-02-14 4:26 pm Sale | 13G | CYMABAY THERAPEUTICS INC CBAY | PERCEPTIVE ADVISORS LLC | 0 0% | -4,242,821 (Position Closed) | View |
| 2020-02-14 4:14 pm Sale | 13G | CYMABAY THERAPEUTICS INC CBAY | BAKER BROS. ADVISORS LP | 0 0% | -4,917,700 (Position Closed) | View |
| 2020-02-14 4:07 pm Sale | 13G | CYMABAY THERAPEUTICS INC CBAY | CITADEL ADVISORS LLC | 2,934,588 4.3% | -158,341 (-5.12%) | View |
| 2020-02-14 4:05 pm Sale | 13G | CYMABAY THERAPEUTICS INC CBAY | Newtyn Management LLC | 0 0% | -3,698,061 (Position Closed) | View |
| 2020-02-14 1:13 pm Purchase | 13D | CYMABAY THERAPEUTICS INC CBAY | ENGINE CAPITAL L.P. | 6,687,253 9.7% | 1,703,319 (+34.18%) | View |
| 2020-02-14 10:21 am Purchase | 13G | CYMABAY THERAPEUTICS INC CBAY | Avoro Capital Advisors LLC | 5,500,000 8% | 5,500,000 (New Position) | View |
| 2020-02-13 9:17 pm Sale | 13G | CYMABAY THERAPEUTICS INC CBAY | Foresite Capital Fund III L.P. | 3,819,726 5.6% | -398,633 (-9.45%) | View |
| 2020-02-11 4:44 pm Purchase | 13G | CYMABAY THERAPEUTICS INC CBAY | VANGUARD GROUP INC | 3,691,325 5.37% | 3,691,325 (New Position) | View |
| 2020-02-05 11:45 am Purchase | 13G | CYMABAY THERAPEUTICS INC CBAY | BlackRock Inc. BLK | 5,589,851 8.1% | 428,270 (+8.30%) | View |
| 2020-01-23 4:46 pm Sale | 13G | CYMABAY THERAPEUTICS INC CBAY | INTEGRATED CORE STRATEGIES (US) LLC | 2,993,645 4.4% | -704,580 (-19.05%) | View |
| 2019-12-20 4:02 pm Purchase | 13G | CYMABAY THERAPEUTICS INC CBAY | CITADEL ADVISORS LLC | 3,092,929 4.5% | 3,092,929 (New Position) | View |